Zhou et al. (Zhou et al. 2020c) found significantly increased circulating proportions of CD14+CD16+ monocytes in peripheral blood from 33 hospitalized patients with diagnosed COVID-19, and this percentage was substantially increased in COVID-19 patients with ARDS. This evidence concerns the gene CD14 and COVID-19.